Digital Health Technology Assessment – Challenges and opportunities ... Changes to Health Technology Assessment in Europe offer new opportunities to streamline processes and get innovative treatments to market faster
R&D Partner Content 3rd World ADC Asia Optimising Physiochemical, Potency & Impurity Analytical Methods to Ensure Regulatory Compliance
R&D Partner Content CRISPR-Based Therapy Analytical Development Summit CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.